Annual FCF
-$22.72 M
-$2.93 M-14.83%
September 30, 2024
Summary
- As of February 26, 2025, EPIX annual free cash flow is -$22.72 million, with the most recent change of -$2.93 million (-14.83%) on September 30, 2024.
- During the last 3 years, EPIX annual FCF has risen by +$2.70 million (+10.62%).
- EPIX annual FCF is now -991.50% below its all-time high of -$2.08 million, reached on September 30, 2014.
Performance
EPIX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$6.47 M
-$3.10 M-92.21%
December 31, 2024
Summary
- As of February 26, 2025, EPIX quarterly free cash flow is -$6.47 million, with the most recent change of -$3.10 million (-92.21%) on December 31, 2024.
- Over the past year, EPIX quarterly FCF has dropped by -$3.10 million (-92.21%).
- EPIX quarterly FCF is now -83048.72% below its all-time high of $7800.00, reached on March 31, 2014.
Performance
EPIX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$22.40 M
+$317.00 K+1.40%
December 31, 2024
Summary
- As of February 26, 2025, EPIX TTM free cash flow is -$22.40 million, with the most recent change of +$317.00 thousand (+1.40%) on December 31, 2024.
- Over the past year, EPIX TTM FCF has increased by +$317.00 thousand (+1.40%).
- EPIX TTM FCF is now -21541.74% below its all-time high of -$103.50 thousand, reached on March 31, 2014.
Performance
EPIX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
EPIX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.8% | -92.2% | +1.4% |
| 3 y3 years | +10.6% | -92.2% | +1.4% |
| 5 y5 years | -85.4% | -92.2% | +1.4% |
EPIX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -14.8% | +18.9% | -92.2% | +22.8% | -13.2% | +20.3% |
| 5 y | 5-year | -85.4% | +18.9% | -92.5% | +22.8% | -62.8% | +20.3% |
| alltime | all time | -991.5% | +18.9% | <-9999.0% | +22.8% | <-9999.0% | +20.3% |
ESSA Pharma Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | -$6.47 M(+92.2%) | -$22.40 M(-1.4%) |
| Sep 2024 | -$22.72 M(+14.8%) | -$3.37 M(-41.4%) | -$22.72 M(-4.7%) |
| Jun 2024 | - | -$5.75 M(-15.7%) | -$23.84 M(+3.7%) |
| Mar 2024 | - | -$6.82 M(+0.5%) | -$23.00 M(+3.6%) |
| Dec 2023 | - | -$6.79 M(+51.2%) | -$22.19 M(+12.2%) |
| Sep 2023 | -$19.78 M(-29.3%) | -$4.49 M(-8.5%) | -$19.78 M(-13.1%) |
| Jun 2023 | - | -$4.91 M(-18.4%) | -$22.77 M(-5.8%) |
| Mar 2023 | - | -$6.01 M(+37.3%) | -$24.18 M(-8.9%) |
| Dec 2022 | - | -$4.38 M(-41.5%) | -$26.56 M(-5.2%) |
| Sep 2022 | -$28.00 M(+10.2%) | -$7.48 M(+18.4%) | -$28.00 M(+0.3%) |
| Jun 2022 | - | -$6.32 M(-24.7%) | -$27.91 M(-0.7%) |
| Mar 2022 | - | -$8.39 M(+44.1%) | -$28.11 M(+3.0%) |
| Dec 2021 | - | -$5.82 M(-21.2%) | -$27.29 M(+7.4%) |
| Sep 2021 | -$25.42 M(+49.7%) | -$7.38 M(+13.3%) | -$25.42 M(+14.6%) |
| Jun 2021 | - | -$6.52 M(-13.9%) | -$22.18 M(+15.8%) |
| Mar 2021 | - | -$7.57 M(+92.1%) | -$19.15 M(+9.0%) |
| Dec 2020 | - | -$3.94 M(-5.0%) | -$17.57 M(+3.4%) |
| Sep 2020 | -$16.98 M(+38.6%) | -$4.15 M(+19.0%) | -$16.98 M(-5.6%) |
| Jun 2020 | - | -$3.49 M(-41.7%) | -$17.98 M(+5.9%) |
| Mar 2020 | - | -$5.98 M(+78.1%) | -$16.99 M(+23.5%) |
| Dec 2019 | - | -$3.36 M(-34.8%) | -$13.76 M(+12.3%) |
| Sep 2019 | -$12.25 M | -$5.15 M(+106.5%) | -$12.25 M(+31.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$2.49 M(-9.5%) | -$9.33 M(-3.2%) |
| Mar 2019 | - | -$2.75 M(+48.9%) | -$9.65 M(-4.7%) |
| Dec 2018 | - | -$1.85 M(-17.1%) | -$10.13 M(-0.9%) |
| Sep 2018 | -$10.22 M(-41.1%) | -$2.23 M(-20.4%) | -$10.22 M(-7.1%) |
| Jun 2018 | - | -$2.81 M(-13.3%) | -$11.00 M(-17.1%) |
| Mar 2018 | - | -$3.24 M(+66.5%) | -$13.27 M(+4.1%) |
| Dec 2017 | - | -$1.94 M(-35.6%) | -$12.74 M(-26.6%) |
| Sep 2017 | -$17.35 M(+13.3%) | -$3.02 M(-40.6%) | -$17.35 M(-2.1%) |
| Jun 2017 | - | -$5.08 M(+87.5%) | -$17.73 M(+10.5%) |
| Mar 2017 | - | -$2.71 M(-58.7%) | -$16.05 M(-16.7%) |
| Dec 2016 | - | -$6.55 M(+93.1%) | -$19.26 M(+25.8%) |
| Sep 2016 | -$15.31 M(+13.3%) | -$3.39 M(+0.1%) | -$15.31 M(-8.7%) |
| Jun 2016 | - | -$3.39 M(-42.8%) | -$16.76 M(-9.2%) |
| Mar 2016 | - | -$5.92 M(+127.5%) | -$18.45 M(+31.9%) |
| Dec 2015 | - | -$2.60 M(-46.3%) | -$13.99 M(+3.6%) |
| Sep 2015 | -$13.51 M(+549.3%) | -$4.84 M(-4.7%) | -$13.51 M(+36.2%) |
| Jun 2015 | - | -$5.08 M(+247.4%) | -$9.92 M(+78.3%) |
| Mar 2015 | - | -$1.46 M(-31.1%) | -$5.56 M(+36.0%) |
| Dec 2014 | - | -$2.12 M(+69.4%) | -$4.09 M(+96.6%) |
| Sep 2014 | -$2.08 M | -$1.25 M(+72.8%) | -$2.08 M(+151.2%) |
| Jun 2014 | - | -$725.00 K(-9394.9%) | -$828.50 K(+700.5%) |
| Mar 2014 | - | $7800.00(-107.0%) | -$103.50 K(-7.0%) |
| Dec 2013 | - | -$111.30 K | -$111.30 K |
FAQ
- What is ESSA Pharma annual free cash flow?
- What is the all time high annual FCF for ESSA Pharma?
- What is ESSA Pharma annual FCF year-on-year change?
- What is ESSA Pharma quarterly free cash flow?
- What is the all time high quarterly FCF for ESSA Pharma?
- What is ESSA Pharma quarterly FCF year-on-year change?
- What is ESSA Pharma TTM free cash flow?
- What is the all time high TTM FCF for ESSA Pharma?
- What is ESSA Pharma TTM FCF year-on-year change?
What is ESSA Pharma annual free cash flow?
The current annual FCF of EPIX is -$22.72 M
What is the all time high annual FCF for ESSA Pharma?
ESSA Pharma all-time high annual free cash flow is -$2.08 M
What is ESSA Pharma annual FCF year-on-year change?
Over the past year, EPIX annual free cash flow has changed by -$2.93 M (-14.83%)
What is ESSA Pharma quarterly free cash flow?
The current quarterly FCF of EPIX is -$6.47 M
What is the all time high quarterly FCF for ESSA Pharma?
ESSA Pharma all-time high quarterly free cash flow is $7800.00
What is ESSA Pharma quarterly FCF year-on-year change?
Over the past year, EPIX quarterly free cash flow has changed by -$3.10 M (-92.21%)
What is ESSA Pharma TTM free cash flow?
The current TTM FCF of EPIX is -$22.40 M
What is the all time high TTM FCF for ESSA Pharma?
ESSA Pharma all-time high TTM free cash flow is -$103.50 K
What is ESSA Pharma TTM FCF year-on-year change?
Over the past year, EPIX TTM free cash flow has changed by +$317.00 K (+1.40%)